The concept draws from hormesis, a biological phenomenon where low-dose exposure to a substance produces beneficial effects while higher doses might produce neutral or even counterproductive outcomes
Cerivastatin, approved by the FDA in 1997, was withdrawn from the market just four years later after 52 deaths as a result of severe rhabdomyolysis 4
C., Molero-Labarta, T., Domnguez-Cabrera, C., Hortal-Cascn, L., Prez-Borges, P., et al
It helps neutralise the free radicals generated by UV exposure and supports your skin's natural repair mechanisms after sun damage occurs
Alissa: For employer groups who are considering covering weight loss, its important to note that while it can initially increase drug spend, it can have a lot of favorable impacts down the line to reduce medical spend